Emergency use authorization medication distribution, utilization, and monitoring in a national integrated healthcare system.
Am J Health Syst Pharm
; 80(8): 518-525, 2023 04 08.
Article
em En
| MEDLINE
| ID: mdl-36566503
ABSTRACT
PURPOSE:
The purpose of this project was to develop and optimize a dashboard and registry to manage the distribution, utilization, and monitoring of coronavirus disease 2019 (COVID-19) emergency use-authorized medications (CEUAMs).SUMMARY:
CEUAMs have specific requirements that must be met for prescribing, monitoring, and compliance. When remdesivir, the first COVID-19 medication with emergency use authorization (EUA), was approved, it immediately became necessary for the Veterans Health Administration, a national integrated health system, to describe the requirements for EUA, to distribute the medication in a fair and equitable manner, and to ensure compliance with all EUA requirements. A dashboard was developed and iteratively updated as additional CEUAMs were approved. The dashboard tracked CEUAM distribution and monitoring at the national, regional, facility, and patient level. Par stock levels were initially determined at the national level. Facilities were also able to request an additional allotment of medication based on demand and allocated supplies from the Department of Health and Human Services. Providers completed a questionnaire for the CEUAM for each patient to ensure all requirements for the medication were met. If there were data integrity concerns, the entry was flagged for review at the facility level and, upon evaluation, corrections were made.CONCLUSION:
Development of the dashboard was resource intensive but provided an excellent mechanism to share information among facilities and national offices. Other healthcare systems can develop similar dashboards to ensure appropriate use of CEUAMs for their patients while meeting all CEUAM requirements.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Prestação Integrada de Cuidados de Saúde
/
COVID-19
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article